
Vogloyd 3D 2.3 Tablet ER
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vogloyd 3D 2.3 Tablet ER
Diabexe 2.3 Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexe 2.3 ER should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially severe complications like kidney disease, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your doctor.
Uses of Vogloyd 3D 2.3 Tablet ER
Managing type 2 diabetes
Major Benefits of Vogloyd 3D 2.3 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogloyd 3D 2.3 Tablet ER should be taken on an empty stomach.
Common Side effects of Vogloyd 3D 2.3 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vogloyd 3D 2.3 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vogloyd 3D 2.3 Tablet ER should be administered on an empty stomach.
How Vogloyd 3D 2.3 Tablet ER works:
Vogloyd 3D 2.3 Extended-Release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogloyd 3D 2.3 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Vogloyd 3D 2.3 Tablet ER during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vogloyd 3D 2.3 tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Extended-release Vogloyd 3D 2.3 tablets are likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, their use is discouraged in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Vogloyd 3D 2.3 Tablet ER cautiously, potentially requiring dosage modification. Medical advice is essential. In those with mild to moderate hepatic dysfunction, initiating treatment with a low dose of Vogloyd 3D 2.3 Tablet ER is typical; however, its use is contraindicated in severe liver disease.
What if you forget to take Vogloyd 3D 2.3 Tablet ER :
Should you forget a dose of Vogloyd 3D 2.3 ER Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogloyd 3D 2.3 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
